Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Baha, Warda ^a,b   Foullous, Abderrahim ^a   Dersi, Noureddine ^a   They They, Thierry Paluku ^c,d   Alaoui, Khadija El ^c   Nourichafi, Nadia ^c   Oukkache, Bouchra ^d   Lazar, Fatiha ^a   Benjelloun, Soumaya ^a   Ennaji, My Mustapha ^b   Elmalki, Abdelouhad ^a   Mifdal, Hassan ^c   Bennani, Abdelouaheb ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^c Regional Blood Transfusion Center   (Morocco)

^d IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Blood donors; General population; Hepatitis B; Hepatitis C; Morocco; Prevalence; Risk factors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD DONOR; CHILD; CROSS INFECTION; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; MOROCCO; PRESCHOOL CHILD; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MOROCCO; POPULATION SURVEILLANCE; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84872323426     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-50     Document Type: Article

References (47)

1. World Health Organization, Western Pacific regional plan for hepatitis B control through immunization Philippines: Regional Office for the Western Pacific Manila [ http://www.wpro.who.int/publications/publications.htm ]. Accessed 5 January 2009
2. Chronic hepatitis B. Lok AS, McMahon BJ, Hepatology 2007 45 507 539 10.1002/hep.21513 17256718
3. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Sood S, Malvankar S, Indian J Community Med 2010 35 165 169 10.4103/0970-0218.62588 20606944
4. World Health Organization, Hepatitis C [ http://www.who.int/mediacentre/ factsheets/fs164/en ]. Accessed 27 April 2009
5. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of china: a cross-sectional study in 2007. Jian L, Yongdong Z, Xiaojing L, Yongzhen J, Ruiguang T, Yonghui Z, Jia W, Fengwei Z, Yong Z, Yue W, Shengli B, PLoS One 2009 4 8467 10.1371/journal.pone.0008467 20041146
6. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Yoshizawa H, Oncology 2002 62 Suppl. 1 8 17 10.1159/000048270 11868791
7. Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco. Belbacha I, Cherkaoui I, Akrim M, Dooley KE, El Aouad R, East Mediterr Health J 2011 17 12 911 919 22355943
8. Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco. Zohoun A, Hadef R, Zahid H, Benkirane M, Med Trop 2011 71 5 513 514
9. Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M, Pathol Biol 2009 57 368 372 10.1016/j.patbio. 2008.07.006 18842351
10. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. Rouabhia S, Malek R, Bounecer H, Dekaken A, Bendali Amor F, Sadelaoud M, Benouar A, World J Gastroenterol 2010 16 3427 31 10.3748/wjg.v16.i27.3427 20632447
11. Routine screening for anti-HIV antibodies, hepatitis B surface antigen and anti-hepatitis C antibodies among general hospital in-patients. Zaied A, Elneihoum A, Elzouki A, Jamahiriya Med J 2010 8 21
12. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I, Lancet 2000 355 887 891 10.1016/S0140-6736(99)06527-7 10752705
13. Epidemiologic and virologic study of hepatitis C virus infections in Morocco. Cacoub P, Ohayon V, Sekkat S, Dumont B, Sbai A, Lunel F, Benslimane A, Godeau P, Archane MI, Gastroenterol Clin Biol 2000 24 2 169 173 12687957
14. Hepatitis C in a French population based survey, 1994: seroprevalence, frequency of viremia, genotype distribution and risk factors. Dubois F, Desenclos JC, Mariotte N, Goudeau A, Hepatology 1997 25 1490 1496 10.1002/hep.510250630 9185773
15. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population: a community based survey in southern Italy. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M, Hepatology 1997 26 1006 1011 10.1002/hep.510260431 9328327
16. The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, N Engl J Med 1992 327 1899 1905 10.1056/NEJM199212313272702 1280771
17. Epidemiology of hepatitis C in Belgium: present and future. Van Damme P, Thyssen A, Van Loock F, Acta Gastroenterol Belg 2002 65 78 79 12148442
18. Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2011 60 17 537 541 21544042
19. Surveillance and epidemiology of hepatitis B and C in Europe-a review. Rantala M, van de Laar MJ, Euro Surveill 2008 22 13(21)
20. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F, B Soc Pathol Exot 1995 88 225 228
21. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K, Trans R Soc Trop Med Hyg 1997 91 11 14 10.1016/S0035-9203(97)90374-6 9093616
22. Hepatocellular carcinoma in the Asia pacific region. Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. Yuen MF, Hou JL, Chutaputti A, J Gastroenterol Hepatol 2009 24 346 353 10.1111/j.1440-1746.2009.05784.x 19220670
23. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B endemic area. Lee HS, Han CJ, Kim CY, Cancer 1993 72 2564 2567 10.1002/1097-0142(19931101)72:9<2564::AID-CNCR2820720909>3.0.CO;2-# 8402477
24. Clinical features of hepatocellular carcinoma in the 1990s. Jung SH, Kim BH, Joung YH, Han YS, Lee BH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R, Korean J Gastroenterol 2003 42 322 329 14634352
25. Prevalence of chronic hepatitis B and hepatitis C among first time blood donors in northeast Bosnia and Herzegovina: An estimate of prevalence in general population. Petrovic J, Salkic N, Ahmetagic S, Stojic V, MottDivkovic S, Hepat Mon 2011 11 629 633 10.5812/kowsar.1735143X.1506 22140386
26. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal. Dutta S, Shivananda PG, Chatterjee A, Indian J Public Health 1994 38 108 112 7774971
27. Age-specific prevalence of hepatitis B surface antigen in pediatric population of Aligarh, North India. Qamer S, Shahab T, Alam S, Malik A, Afzal K, Indian J Pediatr 2004 71 965 967 10.1007/BF02828107 15572813
28. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia. Ben Halima S, Bahri O, Maamouri N, Cheikh I, Alaya NB, Sadraoui A, Azaiez O, Azouz M, Mami NB, Triki H, North Africa. Virol J 2010 15 7 229
29. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients. El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM, J Gastroenterol 2009 44 359 364 10.1007/s00535-009-0020-3 19271112
30. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, Rizzetto M, J Hepatol 2003 39 1036 1041 10.1016/S0168-8278(03)00470-7 14642623
31. Clinical and virological profiles in patients with multiple hepatitis virus infections. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A, Gastroenterology 1993 105 1529 1533 10.1016/0016-5085(93) 90161-5 8224658
32. Characteristics of patients with dual infection by hepatitis B and C viruses. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D, J Hepatol 1998 28 27 33 10.1016/S0168-8278(98)80198-0 9537860
33. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J, Hepatology 2001 34 404 410 10.1053/jhep.2001.26511 11481626
34. Prevalence of markers of hepatitis B virus infection in various countries: a WHO Collaborative Study. Sobeslavsky O, Bull World Health Organ 1980 58 4 621 628 6969134
35. Infectious risks associated with blood exposure for traditional barbers and their customers in Morocco. Zahraoui-Mehadji M, Baakrim MZ, Laraqui S, Laraqui O, El Kabouss Y, Verger C, Caubet A, Laraqui CH, Sante 2004 14 4 211 216 15745870
36. Hepatitis B prevalence and risk factors in Morocco. Sbai A, Baha W, Ougabrai H, Allalia T, Dersi N, Lazaar F, Ennaji MM, Benjouad A, El Malki A, Hassar M, Benani A, Pathol Biol (Paris) 2012 60 5 65 e69 10.1016/j.patbio.2011. 06.001
37. Seroprevalence of hepatitis B: Do blood donors represent the general population? Karaosmanoglu HK, Aydin OA, Sandikci S, Yamanlar ER, Nazlican O, J Infect Dev Ctries 2012 6 181 183 22337848
38. Prévalence des marqueurs sériques du virus de l'hépatite C chez une population de donneurs de sang. Sbiti M, Bahji M, Zahid H, Benkirane M, Naji M, Bouhamidi B, El jouadi A, gaz transfus 2002 Juillet-aout 8 10
39. Frequency of hepatitis B, C, and HIV viruses among blood donors in Libya. Khmmaj A, Habas E, Azabi M, Libyan J Med 2010 5 5333
40. Prevalence of antibodies against hepatitis C virus in the adult German population. Palitzsch KD, Hottentrager B, Schollotmann K, Eur J Gastroenterol Hepatol 1999 11 1215 1220 10.1097/00042737-199911000-00005 10563529
41. Virus de l'hépatite C chez les donneurs de sang dans la région de Monastir (Tunisie): Prévalence et facteurs de risque. Mastouri M, Ben othman S, Bouzgarrou N, Hassin M, Pozzetto B, Trabelsi A, Khedhei M, MHA 2004 16 59 62
42. Hepatitis C antibodies among blood donors in Senegal. Etard JF, Colbachini P, Dromigny JA, Emerg Infect Dis 2001 9 1492 1493
43. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. Alter MJ, Kruszon-Moran D, Nainan OV, N Engl J Med 1999 341 556 562 10.1056/NEJM199908193410802 10451460
44. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Muroz-Gomez R, Garcia-Monzon C, Garcia-Buey L, Eur J Gastroenterol Hepatol 1996 8 273 277 10.1097/00042737-199603000-00016 8724030
45. Large scale HCV RNA screening in first time blood donors; the first step towards genomic screening of blood donations. HCV RNA screening study group. Petrik J, Hewitt P, Barbara J, Allain J, Vox Sang 1999 76 159 162 10.1046/j.1423-0410.1999.7630159.x 10341330
46. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. Ghavanini AA, Sabri MR, East Mediterr Health J 2000 6 1114 1116 12197336
47. Changing epidemiology of hepatitis B in a US community. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ, Hepatology 2004 39 811 816 10.1002/hep.20098 14999701